Positron-emission tomography with [18F]fluorodeoxyglucose: Part I. Biochemical uptake mechanism and its implication for clinical studies

Journal of Cancer Research and Clinical Oncology

Volumn 126, Issue 10, 2000, Pages 549-559

  Pauwels, E K J ^a   Sturm, E J C ^a   Bombardieri, E ^b   Cleton, F J ^a   Stokkel, M P M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

FDG; Malignancy; PET; Uptake mechanism

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CITRIC ACID CYCLE; DIAGNOSTIC IMAGING; DRUG UPTAKE; GLUCOSE TRANSPORT; GLYCOLYSIS; HYPERGLYCEMIA; HYPOXIA; MALIGNANT NEOPLASTIC DISEASE; MONITORING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW;

EID: 0033797094     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00008465     Document Type: Review

References (90)

1. Protein kinase activity of rat brain hexokinase
2. Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP
3. Glucose utilization by tumor cells: The enzyme hexokinase autophosphorylates both its N-and C-terminal halves
4. Structure/function relationships in hexokinase. Site-directed mutational analyses and characterization of overexpressed fragments implicate different functions for the N- and C-terminal halves of the enzyme
5. Mammalian passive glucose transporters: Members of an ubiquitous family of active and passive transport proteins
6. Quantitation and immunolocalization of glucose transporters in the human placenta
7. Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription
8. Glucose transporter proteins in human insulinoma
9. Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation
10. Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?
11. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study
12. High aerobic glycolysis of rat hepatoma cells in culture: Role of mitochondrial hexokinase
13. Facilitated diffusion of glucose
14. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia
15. High expression of the Glut1 glucose transporter in human brain hemangioblastoma endothelium
16. Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: A preliminary observation
17. FDG-PET in oncology: There's more to it than looking at pictures
18. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes
19. Hexokinase binding to mitochondria: A basis for proliferative energy metabolism
20. The genes of hepatic glucose metabolism
21. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites
22. Tissue distribution of the human GLUT3 glucose transporter
23. GLUT1 glucose transporter expression in benign and malignant thyroid nodules
24. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy
25. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake
26. From receptor to transporter: Insulin signalling to glucose transport
27. Non-glycolytic acidification of murine radiation-induced fibrosarcoma 1 tumor via 3-O-methyl-D-glucose monitored by 1H, 2H, 13C, and 31P nuclear magnetic resonance spectroscopy
28. +/glucose cotransporter cloned from rabbit small intestine
29. Characterization of rat GLUT5 and functional analysis of chimeric proteins of GLUT1 glucose transporter and GLUT5 fructose transporter
30. Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut
31. Evidence that transcription of the hexokinase gene is increased in a rapidly growing rat hepatoma
32. Proteins that interact with facilitative glucose transporters: Implication for function
33. +/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose
34. Regulation of glucose-transporter function
35. Human facilitative glucose transporters. Isolation, functional characterization, and gene localization of cDNAs encoding an isoform (GLUT5) expressed in small intestine, kidney, muscle, and adipose tissue and an unusual glucose transporter pseudogene-like sequence (GLUT6)
36. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography
37. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake
38. Glucose transporter 2 (GLUT 2): Expression in specific brain nuclei
39. Immunolocalization of GLUT1 and GLUT3 glucose transporters in primary cultured neurons and glia
40. Substrate specificity and kinetic parameters of GLUT3 in rat cerebellar granule neurons
41. Jejunal/kidney glucose transporter isoform (Glut-5) is expressed in the human blood-brain barrier
42. Glucose catabolism in cancer cells. Isolation, sequence, and activity of the promoter for type II hexokinase
43. Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53
44. Expression of glucose transporters in head-and-neck tumors
45. Growth factors, mitogens, oncogenes and the regulation of glucose transport
46. Sugar-dependent expression of the fructose transporter GLUT5 in Caco-2 cells
47. Polarity of transport of 2-deoxy-D-glucose and D-glucose by cultured renal epithelia (LLC-PK1)
48. Fluorodeoxyglucose imaging: A method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors
49. Differential responses of intestinal glucose transporter mRNA transcripts to levels of dietary sugars
50. Characterization of the rabbit intestinal fructose transporter (GLUT5)
51. Facilitative glucose transporters
52. Immunohistochemical localization of glucose transporters in human renal cell carcinoma
53. Contributions of glycolysis and oxidative phosphorylation to adenosine 5'-triphosphate production in AS-30D hepatoma cells
54. The interaction among glucose transport, hexokinase, and glucose-6-phosphatase with respect to 3H-2-deoxyglucose retention in murine tumor models
55. Distribution of the glucose transporters in human brain tumors
56. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: Characterization of tumor and assessment of effect of treatment
57. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method
58. D-19575 - A sugar-linked isophosphoramide mustard derivative exploiting transmembrane glucose transport
59. Mammalian glucokinase
60. Moving GLUT4: The biogenesis and trafficking of GLUT4 storage vesicles
61. Expression of facilitative glucose transport proteins during development of squamous cell carcinomas of the head and neck
62. Differences in expression and intracellular distribution of hexokinase isoenzymes in rat liver cells of different transformation stages
63. Glucose catabolism in cancer cells: Regulation of the Type II hexokinase promoter by glucose and cyclic AMP
64. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose
65. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: A re-examination
66. Glucose regulates glut 1 function and expression in fetal rat lung and muscle in vitro
67. Alterations in glucose metabolism in chick embryo cells transformed by Rous sarcoma virus. Transformation-specific changes in the activities of key enzymes of the glycolytic and hexose monophosphate shunt pathways
68. Fluorodeoxyglucose cell incorporation as an index of cell proliferation: Evaluation of accuracy in cell culture
69. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat
70. The applications of PET in clinical oncology
71. Cellular stress causes accumulation of the glucose transporter at the surface of cells independently of their insulin sensitivity
72. Expression and localization of glucose transporter 1 (GLUT1) in the rat oviduct: A possible supplier of glucose to embryo during early embryonic development
73. Differential regulation of two glucose transporters by chronic growth hormone treatment of cultured 3T3-F442A adipose cells
74. Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells
75. Liver glucose transporter: A basolateral protein in hepatocytes and intestine and kidney cells
76. The role of insulin in activation of two enhancers in the mouse GLUT1 gene
77. Effect of hyperglycemia on in vitro tumor uptake of tritiated FDG, thymidine, L-methionine and L-leucine
78. +/glucose cotransporter gene SGLT1
79. Cloning and expression of a hepatic microsomal glucose transport protein. Comparison with liver plasma-membrane glucose-transport protein GLUT 2
80. Primary and metastatic breast carcinoma: Initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose
81. Serum glucose: Effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma
82. Purification and characterization of hypoxia-inducible factor 1
83. Glucose transport stimulation by thyroid hormone in ARL 15 cells: Partial role of increased GLUT1 glucose transporter gene transcription
84. Regulation of cell surface GLUT1, GLUT3, and GLUT4 by insulin and IGF-I in L6 myotubes
85. Over-expression of facilitative glucose transporter genes in human cancer
86. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers
87. Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival
88. Expression of the fructose transporter GLUT5 in human breast cancer